Proteome Sciences plc (LON:PRM) has today announced that Mr Richard Dennis has today been appointed to the Board of Directors. As communicated on 3 April 2017, when he joined the Company as its first Chief Commercial Officer, Mr Dennis has over 30 years’ experience in the sector gained most recently as Director of International Commercial Operations at Quanterix Corp, and prior to that in positions of increasing responsibility at Bioscale Inc. and Meso Scale Discovery.
Commenting on this appointment, Jeremy Haigh, Chief Executive Officer, said: “I am delighted to welcome Richard to the Board. Since joining a year ago Richard has transformed our commercial identity and ambition with his focus on face to face selling, account management, and an established client network across Europe. His arrival heralded a relaunch of our services business and inspired a complete review of our commercial practice resulting in the adoption of an agent-based sales model in our principal operating territories. His deep experience of strategic sales and marketing within the bioscience sector will be an asset to the Board at this critical juncture in the Company’s development”